Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

The discovery of cell wall active antibacterial antibiotics.

Gadebusch HH, Stapley EO, Zimmerman SB.

Crit Rev Biotechnol. 1992;12(3):225-43. Review. No abstract available.

PMID:
1633621
2.

A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceus.

Chang RS, Lotti VJ, Monaghan RL, Birnbaum J, Stapley EO, Goetz MA, Albers-Schönberg G, Patchett AA, Liesch JM, Hensens OD, et al.

Science. 1985 Oct 11;230(4722):177-9.

PMID:
2994227
3.

Use of a computer to group actinomycetes for studies on the ecology of soil microorganisms.

Keast D, Rowe P, Sanfelieu L, Shannahan J, Bowra B, Skates S, Stapley EO, Woodruff HB.

Appl Environ Microbiol. 1984 Oct;48(4):791-6.

4.

Discovery, production and purification of the Na+, K+ activated ATPase inhibitor, L-681,110 from the fermentation broth of Streptomyces sp. MA-5038.

Huang L, Albers-Schonberg G, Monaghan RL, Jakubas K, Pong SS, Hensens OD, Burg RW, Ostlind DA, Conroy J, Stapley EO.

J Antibiot (Tokyo). 1984 Sep;37(9):970-5.

5.

Studies on the ecology of West Australian actinomycetes: Factors which influence the diversity and types of actionomycetes in Australian soils.

Keast D, Rowe P, Bowra B, Sanfelieu L, Stapley EO, Woodruff HB.

Microb Ecol. 1984 Jun;10(2):123-36. doi: 10.1007/BF02011420.

PMID:
24221093
6.

Ivermectin: a potent new antiparasitic agent.

Campbell WC, Fisher MH, Stapley EO, Albers-Schönberg G, Jacob TA.

Science. 1983 Aug 26;221(4613):823-8.

PMID:
6308762
7.
8.

Epithienamycins. II. Isolation and structure assignment.

Cassidy PJ, Albers-Schonberg G, Goegelman RT, Miller T, Arison B, Stapley EO, Birnbaum J.

J Antibiot (Tokyo). 1981 Jun;34(6):637-48.

9.

Epithienamycins-novel beta-lactams related to thienamycin. I. Production and antibacterial activity.

Stapley EO, Cassidy PJ, Tunac J, Monaghan RL, Jackson M, Hernandez S, Zimmerman SB, Mata JM, Currie SA, Daoust D, Hendlin D.

J Antibiot (Tokyo). 1981 Jun;34(6):628-36.

10.

An animal model for assessing pain-on-injection of antibiotics.

Celozzi E, Lotti VJ, Stapley EO, Miller AK.

J Pharmacol Methods. 1980 Dec;4(4):285-9.

PMID:
7206736
11.

In vivo inoculum effect and resistance selection with cefamandole and cefoxitin against Enterobacter cloacae in mice.

Miller AK, Celozzi E, Pelak BA, Birnbaum J, Stapley EO.

J Antimicrob Chemother. 1980 Nov;6(6):804-6. No abstract available.

PMID:
7002900
12.

Correlation of in vitro susceptibility with in vivo efficacy in mice for cefoxitin in comparison with cephalosporins.

Miller AK, Celozzi E, Pelak BA, Birnbaum J, Stapley EO.

J Antimicrob Chemother. 1979 Sep;5(5):569-79.

PMID:
315403
13.

Heneicomycin, a new antibiotic (A21A): fermentation, isolation, and antibacterial spectrum.

Zimmerman SB, Chalmers JH Jr, Dewey RS, Stapley EO, Hernandez S.

J Antibiot (Tokyo). 1979 Jun;32(6):665-6. No abstract available.

14.

Avermectins, new family of potent anthelmintic agents: producing organism and fermentation.

Burg RW, Miller BM, Baker EE, Birnbaum J, Currie SA, Hartman R, Kong YL, Monaghan RL, Olson G, Putter I, Tunac JB, Wallick H, Stapley EO, Oiwa R, Omura S.

Antimicrob Agents Chemother. 1979 Mar;15(3):361-7.

15.

Evolution of an antibiotic screening programme. A tribute to Justo Martinez Mata.

Woodruff HB, Hernandez S, Stapley EO.

Hindustan Antibiot Bull. 1979 Feb;21(3):71-84. Review. No abstract available.

PMID:
396280
16.

Thienamycin, a new beta-lactam antibiotic. I. Discovery, taxonomy, isolation and physical properties.

Kahan JS, Kahan FM, Goegelman R, Currie SA, Jackson M, Stapley EO, Miller TW, Miller AK, Hendlin D, Mochales S, Hernandez S, Woodruff HB, Birnbaum J.

J Antibiot (Tokyo). 1979 Jan;32(1):1-12.

17.

Cefoxitin and cephamycins: microbiological studies.

Stapley EO, Birnbaum J, Miller AK, Wallick H, Hendlin D, Woodruff HB.

Rev Infect Dis. 1979 Jan-Feb;1(1):73-89. Review.

PMID:
400941
18.

[Cefoxitin, a new semi-synthetic cephamycin (author's transl)].

Stapley EO, Birnbaum J.

Sem Hop. 1978 Oct 8-15;54(29-32):975-81. French.

PMID:
216093
19.

Cefoxitin, a semi-synthetic cephamycin: a microbiological overview.

Birnbaum J, Stapley EO, Miller AK, Wallick H, Hendlin D, Woodruff HB.

J Antimicrob Chemother. 1978 Jul;4(B):15-32. Review. No abstract available.

PMID:
357379
20.

Fosfomycin: Laboratory studies.

Woodruff HB, Mata JM, Hernández S, Mochales S, Rodríguez A, Stapley EO, Wallick H, Miller AK, Hendlin D.

Chemotherapy. 1977;23 Suppl 1:1-22.

PMID:
583866
21.

Fosfomycin treatment of Haemophilus influenzae infection in mice.

Miller AK, Kong YL, Stapley EO.

Chemotherapy. 1977;23 Suppl 1:75-81.

PMID:
299838
22.

Relative morphological effects induced by cefoxitin and other beta-lactam antibiotics in vitro.

Zimmerman SB, Stapley EO.

Antimicrob Agents Chemother. 1976 Feb;9(2):318-26.

23.

Observations on the mode of action of cefoxitin.

Onishi HR, Zimmerman SB, Stapley EO.

Ann N Y Acad Sci. 1974 May 10;235(0):406-25. No abstract available.

PMID:
4604846
24.

Cefoxitin, a semisynthetic cephamycin antibiotic: in vivo evaluation.

Miller AK, Celozzi E, Kong Y, Pelak BA, Hendlin D, Stapley EO.

Antimicrob Agents Chemother. 1974 Jan;5(1):33-7.

25.

Cefoxitin, a semisynthetic cephamycin antibiotic: resistance to beta-lactamase inactivation.

Onishi HR, Daoust DR, Zimmerman SB, Hendlin D, Stapley EO.

Antimicrob Agents Chemother. 1974 Jan;5(1):38-48.

26.

Cephamycins, a new family of beta-lactam antibiotics. I. Production by actinomycetes, including Streptomyces lactamdurans sp. n.

Stapley EO, Jackson M, Hernandez S, Zimmerman SB, Currie SA, Mochales S, Mata JM, Woodruff HB, Hendlin D.

Antimicrob Agents Chemother. 1972 Sep;2(3):122-31.

27.

Cephamycins, a new family of beta-lactam antibiotics: antibacterial activity and resistance to beta-lactamase degradation.

Daoust DR, Onishi HR, Wallick H, Hendlin D, Stapley EO.

Antimicrob Agents Chemother. 1973 Feb;3(2):254-61.

28.

Cephamycins, a new family of beta-lactam antibiotics. IV. In vivo studies.

Miller AK, Celozzi E, Kong Y, Pelak BA, Kropp H, Stapley EO, Hendlin D.

Antimicrob Agents Chemother. 1972 Oct;2(4):287-90.

29.

Cephamycins, a new family of beta-lactam antibiotics. 3. In vitro studies.

Miller AK, Celozzi E, Pelak BA, Stapley EO, Hendlin D.

Antimicrob Agents Chemother. 1972 Oct;2(4):281-6.

30.

Azirinomycin. I. Microbial production and biological characteristics.

Stapley EO, Hendlin D, Jackson M, Miller AK, Hernandez S, Mata JM.

J Antibiot (Tokyo). 1971 Jan;24(1):42-7. No abstract available.

31.

Phosphonomycin, a new antibiotic produced by strains of streptomyces.

Hendlin D, Stapley EO, Jackson M, Wallick H, Miller AK, Wolf FJ, Miller TW, Chaiet L, Kahan FM, Foltz EL, Woodruff HB, Mata JM, Hernandez S, Mochales S.

Science. 1969 Oct 3;166(3901):122-3.

PMID:
5809587
32.

Antibiotic MSD-819. Preparation and properties of biologically active derivatives.

Miller TW, Miller AK, Wolf FJ, Stapley EO, Hendlin D.

J Antibiot (Tokyo). 1969 Jul;22(7):293-6. No abstract available.

33.

Phosphonomycin. IV. Susceptibility testing method and survey.

Zimmerman SB, Stapley EO, Wallick H, Baldwin R.

Antimicrob Agents Chemother (Bethesda). 1969;9:303-9. No abstract available.

PMID:
5396505
34.

Phosphonomycin. II. Fermentation studies.

Jackson M, Stapley EO.

Antimicrob Agents Chemother (Bethesda). 1969;9:291-6. No abstract available.

PMID:
5396504
35.

Phosphonomycin. I. Discovery and in vitro biological characterization.

Stapley EO, Hendlin D, Mata JM, Jackson M, Wallick H, Hernandez S, Mochales S, Currie SA, Miller RM.

Antimicrob Agents Chemother (Bethesda). 1969;9:284-90. No abstract available.

PMID:
5396502
36.

Production of the antibiotic D-4-amino-3-isoxazolidone by bacteria.

Stapley EO, Miller TW, Jackson M.

Antimicrob Agents Chemother (Bethesda). 1968;8:268-73. No abstract available.

PMID:
5735372
37.

Antibiotic MSD-819. I. Microbial production and biological characteristics.

Stapley EO, Hendlin D, Mata JM, Hernandez S, Miller AK, Jackson M, Wallick H.

Antimicrob Agents Chemother (Bethesda). 1968;8:249-54. No abstract available.

PMID:
5735368
38.

Antimycoplasmal activity of the bottromycin complex and its production by Streptomyces canadensis.

Miller BM, Stapley EO, Woodruff HB.

Antimicrob Agents Chemother (Bethesda). 1967;7:407-14. No abstract available.

PMID:
5628089
39.

L-4-oxalysine, and antimetabolic antibiotic of microbial origin.

Stapley EO, Miller TW, Mata JM, Hendlin D.

Antimicrob Agents Chemother (Bethesda). 1967;7:401-6. No abstract available.

PMID:
4876092
40.

Histidomycin. I. Production by Norcardia histidans and biological characterization.

Stapley EO, Demny TC, Miller AK, Woodruff HB.

Antimicrob Agents Chemother (Bethesda). 1966;6:595-602. No abstract available.

PMID:
5985294
41.

ANTIBIOTIC MSD-235. I. PRODUCTION BY STREPTOMYCES AVIDINII AND STREPTOMYCES LAVENDULAE.

STAPLEY EO, MATA JM, MILLER IM, DEMNY TC, WOODRUFF HB.

Antimicrob Agents Chemother (Bethesda). 1963;161:20-7. No abstract available.

PMID:
14274896
42.

The identity of porfiromycin and methyl mitomycin.

WAKAKI S, HARADA Y, UZU K, WHITFIELD GB, WILSON AN, KALOWSKY A, STAPLEY EO, WOLF FJ, WILLIAMS DE.

Antibiot Chemother (Northfield). 1962 Jul;12:469-71. No abstract available.

PMID:
14004453
43.
44.

Cross-resistance studies and antibiotic identification.

STAPLEY EO.

Appl Microbiol. 1958 Nov;6(6):392-8. No abstract available.

45.

Similarity of albomycin and grisein.

STAPLEY EO, ORMOND RE.

Science. 1957 Mar 29;125(3248):587-9.

PMID:
13409012
46.

Hydroxylation of progesterone and 11-desoxy-17-hydroxycorticosterone by Aspergillus and Penicillium.

DULANEY EL, MCALEER WJ, KOSLOWSKI M, STAPLEY EO, JAGLOM J.

Appl Microbiol. 1955 Nov;3(6):336-40. No abstract available.

47.

Studies on ergosterol production by yeasts.

DULANEY EL, STAPLEY EO, SIMPF K.

Appl Microbiol. 1954 Nov;2(6):371-9. No abstract available.

Supplemental Content

Loading ...
Support Center